Azitra, Inc. (AZTR) vs MetaVia Inc. (MTVA)

Azitra, Inc. and MetaVia Inc. are both Biotechnology companies. Azitra, Inc. and MetaVia Inc. are of similar size ($10.9M and $10.1M). MetaVia Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Across the 9 metrics below, Azitra, Inc. leads on 5 and MetaVia Inc. on 4.

Valuation

Metric AZTR MTVA Biotechnology median
P/E 2.54 n/m 7.88
P/S 5.66 n/m 11.47
P/B 0.45 1.44 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.31 n/m 0.74
EV/Sales (5.94) n/m 10.73
Earnings yield 39.35% (135.29%) (28.84%)
Free cash flow yield (346.99%) (160.83%) (23.03%)

Profitability

Metric AZTR MTVA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (175.68%) (57.72%)
Return on assets (190.69%) (91.06%) (49.22%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR MTVA Biotechnology median
Revenue growth (TTM) 58.18% — 5.64%
EPS growth (last fiscal year) 85.67% 81.23% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 2.06 4.73
Net debt to EBITDA 0.20 0.75 0.96

Dividend

Metric AZTR MTVA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric AZTR MTVA Biotechnology median
Market cap 10.10m 10.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack